Alpha1-adrenoceptor subtype substitution in knockout mice.
Hieble
J Paul
JP
Department of Urology Research, GlaxoSmithKline, King of Prussia, PA, USA. j_paul_hieble@gsk.ccom
D058668:Adrenergic alpha-1 Receptor Antagonists; D000818:Animals; D001667:Binding, Competitive / Q000187:drug effects; D022781:Hepatocytes / Q000166:cytology / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D010879:Piperazines / Q000378:metabolism / Q000494:pharmacology; D011224:Prazosin / Q000031:analogs & derivatives / Q000378:metabolism; D011869:Radioligand Assay; D018340:Receptors, Adrenergic, alpha-1 / Q000235:genetics / Q000378:metabolism*; D013941:Thymine / Q000378:metabolism / Q000494:pharmacology; D014316:Tritium
C547714:Adra1a protein, mouse; C547717:Adra1b protein, mouse; D058668:Adrenergic alpha-1 Receptor Antagonists; D010879:Piperazines; C120711:RS 100329; D018340:Receptors, Adrenergic, alpha-1; D014316:Tritium; C053428:BMY 7378; D013941:Thymine; D011224:Prazosin